Marc S Zimmer
Examiner (ID: 11482, Phone: (571)272-1096 , Office: P/1765 )
Most Active Art Unit | 1765 |
Art Unit(s) | 1765, 1796, 1712 |
Total Applications | 2564 |
Issued Applications | 2008 |
Pending Applications | 117 |
Abandoned Applications | 439 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 11393922
[patent_doc_number] => 20170014458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-19
[patent_title] => 'MUCOADHESIVE SUSTAINED-RELEASE VAGINAL TABLET'
[patent_app_type] => utility
[patent_app_number] => 15/124148
[patent_app_country] => US
[patent_app_date] => 2015-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5507
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15124148
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/124148 | MUCOADHESIVE SUSTAINED-RELEASE VAGINAL TABLET | Mar 9, 2015 | Abandoned |
Array
(
[id] => 10333519
[patent_doc_number] => 20150218523
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-06
[patent_title] => 'MANUFACTURE OF VASCULAR SMOOTH MUSCLE CELLS AND THE USE'
[patent_app_type] => utility
[patent_app_number] => 14/614889
[patent_app_country] => US
[patent_app_date] => 2015-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 12093
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14614889
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/614889 | MANUFACTURE OF VASCULAR SMOOTH MUSCLE CELLS AND THE USE | Feb 4, 2015 | Abandoned |
Array
(
[id] => 9792278
[patent_doc_number] => 20150004223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-01
[patent_title] => 'BIOEFFECTIVE KRILL OIL COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 14/490176
[patent_app_country] => US
[patent_app_date] => 2014-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 17805
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14490176
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/490176 | Bioeffective krill oil compositions | Sep 17, 2014 | Issued |
Array
(
[id] => 10038212
[patent_doc_number] => 09078905
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-14
[patent_title] => 'Bioeffective krill oil compositions'
[patent_app_type] => utility
[patent_app_number] => 14/490221
[patent_app_country] => US
[patent_app_date] => 2014-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 17810
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14490221
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/490221 | Bioeffective krill oil compositions | Sep 17, 2014 | Issued |
Array
(
[id] => 10799410
[patent_doc_number] => 20160145567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-26
[patent_title] => 'CELL CULTURE ARTICLE AND METHODS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/899394
[patent_app_country] => US
[patent_app_date] => 2014-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8254
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14899394
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/899394 | CELL CULTURE ARTICLE AND METHODS THEREOF | Jun 22, 2014 | Abandoned |
Array
(
[id] => 9989650
[patent_doc_number] => 09034853
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-19
[patent_title] => 'Use of 2-methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D3 to treat secondary hyperparathyroidism'
[patent_app_type] => utility
[patent_app_number] => 14/201091
[patent_app_country] => US
[patent_app_date] => 2014-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 10730
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14201091
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/201091 | Use of 2-methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D3 to treat secondary hyperparathyroidism | Mar 6, 2014 | Issued |
Array
(
[id] => 9306108
[patent_doc_number] => 20140044782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-13
[patent_title] => 'CONTROLLED RELEASE FORMULATIONS OF OPIOID AND NONOPIOID ANALGESICS'
[patent_app_type] => utility
[patent_app_number] => 14/059367
[patent_app_country] => US
[patent_app_date] => 2013-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 48211
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14059367
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/059367 | CONTROLLED RELEASE FORMULATIONS OF OPIOID AND NONOPIOID ANALGESICS | Oct 20, 2013 | Abandoned |
Array
(
[id] => 9307212
[patent_doc_number] => 20140045886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-13
[patent_title] => 'LAQUINIMOD FOR TREATMENT OF GABA MEDIATED DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/964959
[patent_app_country] => US
[patent_app_date] => 2013-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8514
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13964959
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/964959 | Laquinimod for treatment of GABA mediated disorders | Aug 11, 2013 | Issued |
Array
(
[id] => 11356271
[patent_doc_number] => 09532909
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-03
[patent_title] => 'Disposable worn article and method for manufacturing same'
[patent_app_type] => utility
[patent_app_number] => 14/416770
[patent_app_country] => US
[patent_app_date] => 2013-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 4448
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 287
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14416770
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/416770 | Disposable worn article and method for manufacturing same | Jul 24, 2013 | Issued |
Array
(
[id] => 9989591
[patent_doc_number] => 09034793
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-19
[patent_title] => 'Use of ribose to enhance plant growth'
[patent_app_type] => utility
[patent_app_number] => 13/943363
[patent_app_country] => US
[patent_app_date] => 2013-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4827
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13943363
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/943363 | Use of ribose to enhance plant growth | Jul 15, 2013 | Issued |
Array
(
[id] => 9269745
[patent_doc_number] => 20140024663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-23
[patent_title] => 'ATB(0,+) AMINO ACID TRANSPORTER AS A DRUG TARGET FOR TREATMENT OF ESTROGEN RECEPTOR-POSITIVE BREAST CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/940507
[patent_app_country] => US
[patent_app_date] => 2013-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14740
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13940507
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/940507 | ATB(0,+) AMINO ACID TRANSPORTER AS A DRUG TARGET FOR TREATMENT OF ESTROGEN RECEPTOR-POSITIVE BREAST CANCER | Jul 11, 2013 | Abandoned |
Array
(
[id] => 9122146
[patent_doc_number] => 20130289068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-31
[patent_title] => 'ENHANCED MIGRAINE TREATMENTS BASED ON GHRELIN MIMETICS'
[patent_app_type] => utility
[patent_app_number] => 13/920863
[patent_app_country] => US
[patent_app_date] => 2013-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5913
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13920863
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/920863 | Enhanced migraine treatments based on ghrelin mimetics | Jun 17, 2013 | Issued |
Array
(
[id] => 10128161
[patent_doc_number] => 09161982
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-10-20
[patent_title] => 'Sanitizer compositions comprising alcohol and an antimicrobial efficacy enhancer'
[patent_app_type] => utility
[patent_app_number] => 13/917868
[patent_app_country] => US
[patent_app_date] => 2013-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4648
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13917868
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/917868 | Sanitizer compositions comprising alcohol and an antimicrobial efficacy enhancer | Jun 13, 2013 | Issued |
Array
(
[id] => 9263242
[patent_doc_number] => 20130345171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-26
[patent_title] => 'TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASE AND THROMBOSIS'
[patent_app_type] => utility
[patent_app_number] => 13/915299
[patent_app_country] => US
[patent_app_date] => 2013-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 12076
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13915299
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/915299 | Treatment and prevention of cardiovascular disease and thrombosis | Jun 10, 2013 | Issued |
Array
(
[id] => 10121380
[patent_doc_number] => 09155726
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-10-13
[patent_title] => 'Method of treatment using checkpoint kinase 1 inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/913091
[patent_app_country] => US
[patent_app_date] => 2013-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9217
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 200
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13913091
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/913091 | Method of treatment using checkpoint kinase 1 inhibitors | Jun 6, 2013 | Issued |
Array
(
[id] => 10882577
[patent_doc_number] => 08906956
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-09
[patent_title] => 'Composition comprising (−)-Δ9-trans-tetrahydrocannabinol'
[patent_app_type] => utility
[patent_app_number] => 13/912823
[patent_app_country] => US
[patent_app_date] => 2013-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3455
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13912823
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/912823 | Composition comprising (−)-Δ9-trans-tetrahydrocannabinol | Jun 6, 2013 | Issued |
Array
(
[id] => 9977542
[patent_doc_number] => 09023853
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-05
[patent_title] => 'Janus kinase 2 (JAK2) inhibitor for the treatment of lupus'
[patent_app_type] => utility
[patent_app_number] => 13/911447
[patent_app_country] => US
[patent_app_date] => 2013-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 50
[patent_no_of_words] => 17176
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13911447
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/911447 | Janus kinase 2 (JAK2) inhibitor for the treatment of lupus | Jun 5, 2013 | Issued |
Array
(
[id] => 10082551
[patent_doc_number] => 09119881
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-01
[patent_title] => 'Method of synergistically enhancing the therapeutic efficacy and safety of medication through a combination therapy'
[patent_app_type] => utility
[patent_app_number] => 13/905888
[patent_app_country] => US
[patent_app_date] => 2013-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 14253
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13905888
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/905888 | Method of synergistically enhancing the therapeutic efficacy and safety of medication through a combination therapy | May 29, 2013 | Issued |
Array
(
[id] => 9055354
[patent_doc_number] => 20130253068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-26
[patent_title] => 'Cosmetic or Dermatological Preparations Containing Licochalcone A or an Extract of Radix Glycyrrhizae inflatae, Containing Licochalcone A'
[patent_app_type] => utility
[patent_app_number] => 13/897793
[patent_app_country] => US
[patent_app_date] => 2013-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8630
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13897793
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/897793 | Cosmetic or dermatological preparations containing licochalcone A or an extract of radix glycyrrhizae inflatae, containing licochalcone A | May 19, 2013 | Issued |
Array
(
[id] => 9175000
[patent_doc_number] => 20130316985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-28
[patent_title] => 'GPR35 Ligands And Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/897886
[patent_app_country] => US
[patent_app_date] => 2013-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 32637
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13897886
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/897886 | GPR35 Ligands And Uses Thereof | May 19, 2013 | Abandoned |